Percentage density, Wolfe's and Tabár's mammographic patterns: Agreement and association with risk factors for breast cancer

Breast Cancer Research

Volumn 7, Issue 5, 2005, Pages

  Gram, Inger T ^a   Bremnes, Yngve ^a   Ursin, Giske ^b,c   Maskarinec, Gertraud ^d   Bjurstam, Nils ^e   Lund, Eiliv ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^e UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BREAST CANCER; BREAST DENSITY; CANCER HORMONE THERAPY; CANCER SCREENING; CHINESE; CORRELATION COEFFICIENT; DIET; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; LIFESTYLE; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENARCHE; MENSTRUATION; POSTMENOPAUSE; QUANTITATIVE ANALYSIS; REPRODUCTIVE BEHAVIOR; RISK FACTOR; SMOKING; SOFTWARE; BREAST TUMOR; MASS SCREENING; METHODOLOGY; MIDDLE AGED; NORWAY; PATHOLOGY; RADIOGRAPHY; REPRODUCIBILITY;

AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NORWAY; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 27744565436     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1308     Document Type: Article

References (52)

1. Wolfe JN: Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer. 1976, 37: 2486-2492.
2. American College of Radiology: Breast Imaging Reporting and Data System (BI-RADS). 1995, Reston: American College of Radiology, 2
3. Gram IT, Funkhouser E, Tabar L: The Tabar classification of mammographic parenchymal patterns. Eur J Radiol. 1997, 24: 131-136 10.1016/S0720-048X(96)01138-2.
4. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ: Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst. 1995, 87: 670-675.
5. Ursin G, Astrahan MA, Salane M, Parisky YR, Pearce JG, Daniels JR, Pike MC, Spicer DV: The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev. 1998, 7: 43-47.
6. Saftlas AF, Szklo M: Mammographic parenchymal patterns and breast cancer risk. Epidemiol Rev. 1987, 9: 146-174.
7. Oza AM, Boyd NF: Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev. 1993, 15: 196-208 10.2188/jea.15.S196.
8. Gram IT, Funkhouser E, Tabar L: Reproductive and menstrual factors in relation to mammographic parenchymal patterns among perimenopausal women. Br J Cancer. 1995, 71: 647-650.
9. Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH, Seow A, Lee HP, Yu MC: Mammographic Parenchymal Patterns and Self-reported Soy Intake in Singapore Chinese Women. Cancer Epidemiol Biomarkers Prev. 2002, 11: 608-613.
10. Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E: Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med. 1999, 130: 262-269.
11. Freedman M, San Martin J, O'Gorman J, Eckert S, Lippman ME, Lo SC, Walls EL, Zeng J: Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo. J Natl Cancer Inst. 2001, 93: 51-56 10.1093/jnci/93.1.51.
12. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G: Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst. 2003, 95: 30-37.
13. Chow CK, Venzon D, Jones EC, Premkumar A, O'Shaughnessy J, Zujewski J: Effect of tamoxifen on mammographic density. Cancer Epidemiol Biomarkers Prev. 2000, 9: 917-921.
14. Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC: Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst. 1994, 86: 431-436.
15. Boyd NF, Lockwood GA, Martin LJ, Byng JW, Yaffe MJ, Tritchler DL: Mammographic density as a marker of susceptibility to breast cancer: a hypothesis. IARC Sci Publ. 2001, 154: 163-169.
16. Maskarinec G, Williams AE, Carlin L: Mammographic densities in a one-year isoflavone intervention. Eur J Cancer Prev. 2003, 12: 165-169 10.1097/00008469-200304000-00011.
17. Atkinson C, Warren RM, Sala E, Dowsett M, Dunning AM, Healey CS, Runswick S, Day NE, Bingham SA: Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]. Breast Cancer Res. 2004, 6: R170-R179 10.1186/bcr773.
18. Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW: Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst. 2004, 96: 621-628.
19. Couto E, Harrison D, Duffy S, Myles J, Sala E, Warren R, Day N, Luben R, Chen H: Estimation of disease progression parameters from case-control data: application to mammographic patterns and breast cancer natural history. J Epidemiol Biostat. 2001, 6: 235-242 10.1080/135952201753173015.
20. Ciatto S, Visioli C, Paci E, Zappa M: Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer. 2004, 90: 393-396 10.1038/sj.bjc.6601548.
21. Sala E, Warren R, McCann J, Duffy S, Day N, Luben R: Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme. J Med Screen. 1998, 5: 207-212.
22. Warren RM, Young JR, McLean L, Lyons K, Wilson AR, Evans A, Duffy SW, Warsi IM: Radiology review of the UKCCCR Breast Screening Frequency Trial: potential improvements in sensitivity and lead time of radiological signs. Clin Radiol. 2003, 58: 128-132 10.1053/crad.2002.1132.
23. Harrison DA, Duffy SW, Sala E, Warren RM, Couto E, Day NE: Deterministic models for breast cancer progression: application to the association between mammographic parenchymal pattern and histologic grade of breast cancers. J Clin Epidemiol. 2002, 55: 1113-1118 10.1016/S0895-4356(02)00483-3.
24. Wolfe JN, Saftlas AF, Salane M: Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR Am J Roentgenol. 1987, 148: 1087-1092.
25. Warner E, Lockwood G, Tritchler D, Boyd NF: The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prev. 1992, 16: 67-72.
26. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ: Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998, 7: 1133-1144.
27. Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon CC, Pike MC: Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev. 2003, 12: 332-338.
28. Maskarinec G, Meng L: A case-control study of mammographic densities in Hawaii. Breast Cancer Res Treat. 2000, 63: 153-161 10.1023/A:1006486319848.
29. Vacek PM, Geller BM: A prospective study of breast cancer risk using routine mammographic breast density measurements. Cancer Epidemiol Biomarkers Prev. 2004, 13: 715-722.
30. Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH: Mammographic parenchymal patterns and risk of breast cancer at and after a prevalence screen in Singaporean women. Int J Epidemiol. 2000, 29: 11-19 10.1093/ije/29.1.11.
31. Byrne C, Hankinson SE, Pollak M, Willett WC, Colditz GA, Speizer FE: Insulin-like growth factors and mammographic density. Growth Horm IGF Res. 2000, 10 (Suppl A): S24-S25 10.1016/S1096-6374(00)90011-X.
32. Haiman CA, Hankinson SE, De V, Guillemette C, Ishibe N, Hunter DJ, Byrne C: Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat. 2003, 77: 27-36 10.1023/A:1021112121782.
33. van Gils CH, Hendriks JH, Otten JD, Holland R, Verbeek AL: Parity and mammographic breast density in relation to breast cancer risk: indication of interaction. Eur J Cancer Prev. 2000, 9: 105-111 10.1097/00008469-200004000-00006.
34. Byng JW, Yaffe MJ, Lockwood GA, Little LE, Tritchler DL, Boyd NF: Automated analysis of mammographic densities and breast carcinoma risk. Cancer. 1997, 80: 66-74 10.1002/(SICI)1097-0142(19970701)80:1<66::AID-CNCR9>3.0.CO;2-D.
35. Maskarinec G, Meng L, Ursin G: Ethnic differences in mammographic densities. Int J Epidemiol. 2001, 30: 959-965 10.1093/ije/30.5.959.
36. Maskarinec G, Lyu LC, Meng L, Theriault A, Ursin G: Determinants of mammographic densities among women of Asian, Native Hawaiian, and Caucasian ancestry. Ethn Dis. 2001, 11: 44-50.
37. Bjurstam N, Bjorneld L, Warwick J, Sala E, Duffy SW, Nystrom L, Walker N, Cahlin E, Eriksson O, Hafstrom LO, et al: The Gothenburg Breast Screening Trial. Cancer. 2003, 97: 2387-2396 10.1002/cncr.11361.
38. Wolfe JN: Breast parenchymal patterns and their changes with age. Radiology. 1976, 121: 545-552.
39. Fleiss JL: Statistical methods for rates and Proportions. 1981, New York: Wiley, 2
40. SAS/STAT User's Guide. 1999, Cary, NC: SAS Institute Inc
41. Venta LA, Hendrick RE, Adler YT, DeLeon P, Mengoni PM, Scharl AM, Comstock CE, Hansen L, Kay N, Coveler A, et al: Rates and causes of disagreement in interpretation of full-field digital mammography and film-screen mammography in a diagnostic setting. AJR Am J Roentgenol. 2001, 176: 1241-1248.
42. Brisson J, Diorio C, Masse B: Wolfe's parenchymal pattern and percentage of the breast with mammographic densities: redundant or complementary classifications?. Cancer Epidemiol Biomarkers Prev. 2003, 12: 728-732.
43. Funkhouser E, Waterbor JW, Cole P, Rubin E: Mammographic patterns and breast cancer risk factors among women having elective screening. South Med J. 1993, 86: 177-180.
44. Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA: Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control. 2000, 11: 653-662 10.1023/A:1008926607428.
45. El Bastawissi AY, White E, Mandelson MT, Taplin SH: Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control. 2000, 11: 955-963 10.1023/A:1026514032085.
46. Andersson I, Janzon L, Pettersson H: Radiographic patterns of the mammary parenchyma: variation with age at examination and age at first birth. Radiology. 1981, 138: 59-62.
47. Sala E, Warren R, McCann J, Duffy S, Luben R, Day N: High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study. Int J Epidemiol. 2000, 29: 629-636 10.1093/ije/29.4.629.
48. Myles JP, Salmininen T, Duffy SW, Prevost TC, Day NE, Hakama M: Prospective estimation of rates of change in mammographic parenchymal patterns: influence of age and of hormone replacement therapy. Breast. 2004, 13: 56-60 10.1016/j.breast.2003.10.007.
49. Warren R: Hormones and mammographic breast density. Maturitas. 2004, 49: 67-78 10.1016/j.maturitas.2004.06.013.
50. Ursin G, Pike MC, Spicer DV, Porrath SA, Reitherman RW: Can mammographic densities predict effects of tamoxifen on the breast?. J Natl Cancer Inst. 1996, 88: 128-129.
51. Gram IT, Ursin G, Spicer DV, Pike MC: Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatment. Cancer Epidemiol Biomarkers Prev. 2001, 10: 1117-1120.
52. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S: Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA. 2001, 285: 171-176 10.1001/jama.285.2.171.